MedPath

Comparison between two schedules of giving Hepatitis B immunisation in unimmunised HIV-positive children.

Not Applicable
Conditions
Health Condition 1: null- HIV-infected children aged 18 months to 12 years
Registration Number
CTRI/2017/12/010816
Lead Sponsor
niversity College of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

HIV positive children receiving ART, who have not received any immunisation against Hepatitis B

Exclusion Criteria

Children who are Hepatits B surface antigen positive, suffering from Hepatitis C and immunological failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anti HBs titres in both groups after completion of primary immunization scheduleTimepoint: 7 months after first dose of recombinant Hepatitis B vaccine
Secondary Outcome Measures
NameTimeMethod
1Proportion of good responders in both groups <br/ ><br>2Proportion of non-responders in both groups <br/ ><br>3Anti HBs titres at 12 months in both groups <br/ ><br>Timepoint: 12 months after receiving the first dose of recombinant hepatitis B vaccine in both groups; 3 months after thr first dose of hepatitis B vaccine in 4 dose vaccine group
© Copyright 2025. All Rights Reserved by MedPath